Study funded by Sobi and Sanofi.

Download Poster (455.71 KB)

Publication
  • WFH CCS •
  • 24 April, 2025 •
  • •

A plain language summary of the association between joint health and patient reported quality of life outcomes using data from the efanesoctocog alfa Phase 3 clinical trial in adults and adolescents with severe haemophilia A

Christoph Königs, Doris Quon, Cedric Hermans, Emilie Gerard, Nana Kragh, Jérôme Msihid, Duygu Bozkaya, Linda Bystrická, Cecile LeCamus, Elena Santagostino, Annemieke Willemze, Annette von Drygalski

Available materials

Oral Presentation
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

Plain language summary: Efanesoctocog alfa treatment outcomes over 3 years in adults & adolescents with severe haemophilia A in the long-term XTEND-ed study

Robert Klamroth, Stephanie P’ng, Sophie Susen, Davide Matino, Angela Weyand, Toshko Lissitchkov, Young-Shil Park, María Teresa Álvarez Román, Liqi Feng, Helena Palmborg, Jennifer Dumont , Elena Santagostino, Lara Mamikonian, Keiji Nogami

Available materials

Poster
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

Plain language summary of two-year results of weekly efanesoctocog alfa treatment in children with severe haemophilia A: Interim analysis of the XTEND-ed phase 3 study

Lynn Malec, Beatrice Nolan, Anthony KC Chan, Manuela Albisetti, Sheng-Chieh Chou, Bulent Zulfikar, Mindy Simpson, Liqi Feng, Helena Palmborg, Graham Neill, Lydia Abad-Franch, Sriya Gunawardena, Karin Fijnvandraat

Available materials

Poster
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

Efanesoctocog alfa for the perioperative management of dental surgery in participants with severe hemophilia A: 4 years of experience during the XTEND clinical program

Pratima Chowdary, Lynn Malec, Sophie Susen, Stephanie P’ng, Flora Peyvandi, Lara Mamikonian, Elena Santagostino, Graham Neill, Umer Khan, Linda Bystrická, Ming-Ching Shen

Available materials

Oral Presentation
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Major Surgical Outcomes with Efanesoctocog Alfa: 4 Years’ Experience in the XTEND Clinical Program

Liane Khoo, Robert Klamroth, Annette von Drygalski, Sandrine Meunier, Davide Matino, Umer Khan, Elena Santagostino, Lara Mamikonian, Linda Bystrická, Graham Neill, Flora Peyvandi

Available materials

Oral Presentation
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Observational Study of Prophylactic Efanesoctocog Alfa for Joint Health in Hemophilia A: PROTECT-ALT

Te-Fu Weng, Yi-Chih Hsu, Chih-Wei Lee, Da-Ming Yeh, Tong-Ling Chien, Nicole Tsao, Ching-Min Chang

Available materials

Poster
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Joint health outcomes with efanesoctocog alfa in adults/adolescents from XTEND-1 continuing XTEND-ed

Christoph Königs, Annette von Drygalski, Cedric Hermans, Barbara A. Konkle, Paul Van der Valk, Liane Khoo, Nobuaki Suzuki, Erin Feng, Umer Khan, Linda Bystrická, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Robert Klamroth

Available materials

Poster
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Long-term observational joint health study in patients initiating efanesoctocog alfa: baseline data

Jonathan C. Roberts, Larissa Bornikova, Eric Grabowski, Amit Soni, Jennifer Dumont, Charlotte Sensinger, Nicole Tsao

Available materials

Poster
Sign up for alerts